Latest News

On December 31, 2025, Range Resources Corporation announced it would fully redeem its US$600,000,000 8.25% senior notes due 2029 on January 15, 2026, at 101.375% of par plus accrued interest, funded via its existing revolving credit facility. This move retires high-coupon debt while shifting funding to shorter-term bank borrowing, putting the company’s balance sheet choices under closer investor and analyst scrutiny. Next, we’ll examine how funding this bond redemption through the revolving...

Earlier this week, Edgewise Therapeutics used its presentation at the 44th J.P. Morgan Healthcare Conference to outline 2026 milestones, including pivotal GRAND CANYON data for sevasemten in Becker muscular dystrophy, Phase 2 readouts for EDG-7500 in hypertrophic cardiomyopathy, and continued development of its early-stage heart failure candidate EDG-15400. A distinctive aspect of the update is Edgewise’s attempt to build an integrated neuromuscular and cardiovascular franchise, with...

Insiders who bought Carbonxt Group Limited ( ASX:CG1 ) in the last 12 months may probably not pay attention to the...

Snam (BIT:SRG) has issued €500 million of fixed rate green bonds maturing in 2031, aimed at funding climate focused projects. For equity investors, this fresh financing move may influence views on the company’s balance sheet structure and sustainability priorities. See our latest analysis for Snam. That green bond issue comes at a time when Snam’s share price is €5.882, with a 30 day share price return of 5.26% and a 90 day share price return of 11.87%. The 1 year total shareholder return...

Recent analyst reports on Marex Group (MRX) highlight increased optimism around the company’s earnings outlook. Several firms have revised their forecasts higher and reiterated positive ratings, drawing fresh attention to the stock. See our latest analysis for Marex Group. The recent earnings optimism has coincided with a 32.28% 90 day share price return and a 21.80% total shareholder return over the past year, suggesting momentum has been building around Marex Group, which had a last close...

Key Insights Significant control over LG Innotek by public companies implies that the general public has more power to...

Active investing isn't easy, but for those that do it, the aim is to find the best companies to buy, and to profit...

It is hard to get excited after looking at KOSE Holdings' (TSE:4922) recent performance, when its stock has declined...

Nitori Holdings Co., Ltd. ( TSE:9843 ), is not the largest company out there, but it saw significant share price...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Sanrio Company fair value estimate is JP¥5,597 With JP¥4,805...

Kawasaki Heavy Industries, Ltd. ( TSE:7012 ) shares have continued their recent momentum with a 27% gain in the last...

Key Insights Nippon Sanso Holdings' significant public companies ownership suggests that the key decisions are...

Key Insights Oji Holdings' significant retail investors ownership suggests that the key decisions are influenced by...

Liontown Limited ( ASX:LTR ) shareholders will have a reason to smile today, with the analysts making substantial...

Key Insights Lottery's significant individual investors ownership suggests that the key decisions are influenced by...

Dyne Therapeutics (DYN) is back in focus after its appearance at the 44th Annual J.P. Morgan Healthcare Conference, where CEO John G. Cox outlined progress in programs targeting myotonic dystrophy type 1 and Duchenne muscular dystrophy. See our latest analysis for Dyne Therapeutics. Despite recent enthusiasm around Dyne’s neuromuscular programs and conference visibility, the 30 day share price return of 11.61% and year to date share price return of 9.70% contrast with a 1 year total...

Why STAAR Surgical Is Back in Focus After the Failed Alcon Deal STAAR Surgical (STAA) is back on investors’ radar after shareholders rejected its cash sale to Alcon and the company confirmed it will continue as an independent, publicly traded business. That decision has quickly been followed by a broad refresh of the boardroom, new committee structures and an active search for a new chief executive, all with heavy involvement from STAAR’s largest shareholders. See our latest analysis for...

Sky Metals Limited ( ASX:SKY ) insiders who bought shares over the past year were rewarded handsomely last week. The...

Why Worthington Enterprises is on investors’ radar today Worthington Enterprises (WOR) has been drawing attention after a mixed stretch in recent trading, with the share price drifting lower over the past month and past 3 months while longer term returns remain positive. See our latest analysis for Worthington Enterprises. At around US$53.43, the share price has eased in the short term, with a 1 day share price return of a 2.0% decline and a 90 day share price return of a 5.5% decline, while...

Recent coverage indicates that Bechtle AG’s AI-related services are helping drive higher-margin projects and growing recurring managed-service bookings across its European customer base. This shift toward AI-enabled, service-based work highlights how Bechtle may be reshaping its revenue mix toward more resilient, contract-driven income streams. Next, we’ll examine how rising AI-driven, higher-margin managed-service demand could influence Bechtle’s existing investment narrative and risk...

Event context and why it matters for PureCycle PureCycle Technologies (PCT) is in focus after partnering with Churchill Container and 4ocean to supply reusable Run It Back souvenir cups made with its recycled resin at the College Football Playoff National Championship. The program ties every 20 cups sold to the removal of one pound of ocean trash, giving PureCycle a high profile platform for its recycling technology and putting a clear environmental metric in front of fans and investors. See...

XtalPi Holdings Limited previously announced a HK$2.87 billion zero-coupon, unsecured, unsubordinated bond offering due January 26, 2027, issued at par and callable under Regulation S. Beyond raising fresh capital, the unsecured, zero-coupon structure highlights how XtalPi is opting for flexible, non-dilutive funding as it scales its AI-driven drug discovery platform. We will now examine how this emphasis on AI-driven drug discovery progress shapes XtalPi’s investment narrative and future...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...